Loading…
Blood Pressure in Renal Disease: How to Accomplish the Goal?
Summary The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing progression of chronic...
Saved in:
| Published in: | Cardiovascular therapeutics 2012-08, Vol.30 (4), p.193-198 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Request full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c4060-d60d80c2ad39478b38a6a44b88936f114c27559f73b3ef9e628b86fb2b3d23653 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c4060-d60d80c2ad39478b38a6a44b88936f114c27559f73b3ef9e628b86fb2b3d23653 |
| container_end_page | 198 |
| container_issue | 4 |
| container_start_page | 193 |
| container_title | Cardiovascular therapeutics |
| container_volume | 30 |
| creator | Robles, Nicolás R. Hernandez-Gallego, Roman |
| description | Summary
The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing progression of chronic kidney disease as well as cardiovascular morbidity and mortality in renal patients. The renal results of the ACCOMPLISH trial strongly support the recommendation of using calcium channel blockers as second antihypertensive agent added to renin–angiotensin axis‐blocking drugs. This review discusses the validity of these data and their relationship with the cumulative evidence on the effects of calcium antagonists on renal disease progression. |
| doi_str_mv | 10.1111/j.1755-5922.2010.00260.x |
| format | article |
| fullrecord | <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_proquest_miscellaneous_1023536127</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1023536127</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4060-d60d80c2ad39478b38a6a44b88936f114c27559f73b3ef9e628b86fb2b3d23653</originalsourceid><addsrcrecordid>eNqNkF1PwjAUhhujEUX_gumlN5v92LrNkBhgAiYEDVG5bLqtC8ON4roF-Pd2Dndtb3rSPu857QMAxMjGZj1sbOy5ruUGhNgEmVOECEP24QxcdRfnXY2dHrjWeoMQQwHDl6BHiNcgwRUYjHKlEvhWSq3rUsJsC5dyK3IYZloKLR_hTO1hpeAwjlWxyzO9htVawqkS-dMNuEhFruXtae-Dj8nz-3hmzV-nL-Ph3IodM9JKGEp8FBOR0MDx_Ij6ggnHiXw_oCzF2InNc9wg9WhEZRpIRvzIZ2lEIpoQylzaB_dt312pvmupK15kOpZ5LrZS1ZpjRKhLGSaeQf0WjUuldSlTviuzQpRHA_HGHd_wRgtv_s8bd_zXHT-Y6N1pSh0VMumCf7IMMGiBfZbL478b83G4NIWJW20805U8dHFRfnHmUc_lq8WUfy5WI28ShjykP-cJiSo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1023536127</pqid></control><display><type>article</type><title>Blood Pressure in Renal Disease: How to Accomplish the Goal?</title><source>Wiley-Blackwell Open Access Collection</source><creator>Robles, Nicolás R. ; Hernandez-Gallego, Roman</creator><creatorcontrib>Robles, Nicolás R. ; Hernandez-Gallego, Roman</creatorcontrib><description>Summary
The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing progression of chronic kidney disease as well as cardiovascular morbidity and mortality in renal patients. The renal results of the ACCOMPLISH trial strongly support the recommendation of using calcium channel blockers as second antihypertensive agent added to renin–angiotensin axis‐blocking drugs. This review discusses the validity of these data and their relationship with the cumulative evidence on the effects of calcium antagonists on renal disease progression.</description><identifier>ISSN: 1755-5914</identifier><identifier>EISSN: 1755-5922</identifier><identifier>DOI: 10.1111/j.1755-5922.2010.00260.x</identifier><identifier>PMID: 22759229</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Albuminuria - epidemiology ; Albuminuria - therapy ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antihypertensive Agents - therapeutic use ; Blood Pressure - drug effects ; Calcium Channel Blockers - therapeutic use ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - physiopathology ; Cardiovascular Diseases - prevention & control ; Disease Progression ; Diuretics - therapeutic use ; Drug Therapy, Combination ; Evidence-Based Medicine ; Humans ; Hypertension ; Hypertension - drug therapy ; Hypertension - epidemiology ; Hypertension - physiopathology ; Kidney disease ; Kidney Diseases - epidemiology ; Kidney Diseases - physiopathology ; Kidney Diseases - therapy ; Renin-Angiotensin System - drug effects</subject><ispartof>Cardiovascular therapeutics, 2012-08, Vol.30 (4), p.193-198</ispartof><rights>2012 Blackwell Publishing Ltd</rights><rights>2012 Blackwell Publishing Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4060-d60d80c2ad39478b38a6a44b88936f114c27559f73b3ef9e628b86fb2b3d23653</citedby><cites>FETCH-LOGICAL-c4060-d60d80c2ad39478b38a6a44b88936f114c27559f73b3ef9e628b86fb2b3d23653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1755-5922.2010.00260.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1755-5922.2010.00260.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,11562,27924,27925,46052,46476</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1755-5922.2010.00260.x$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22759229$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robles, Nicolás R.</creatorcontrib><creatorcontrib>Hernandez-Gallego, Roman</creatorcontrib><title>Blood Pressure in Renal Disease: How to Accomplish the Goal?</title><title>Cardiovascular therapeutics</title><addtitle>Cardiovasc Ther</addtitle><description>Summary
The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing progression of chronic kidney disease as well as cardiovascular morbidity and mortality in renal patients. The renal results of the ACCOMPLISH trial strongly support the recommendation of using calcium channel blockers as second antihypertensive agent added to renin–angiotensin axis‐blocking drugs. This review discusses the validity of these data and their relationship with the cumulative evidence on the effects of calcium antagonists on renal disease progression.</description><subject>Albuminuria - epidemiology</subject><subject>Albuminuria - therapy</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Blood Pressure - drug effects</subject><subject>Calcium Channel Blockers - therapeutic use</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - physiopathology</subject><subject>Cardiovascular Diseases - prevention & control</subject><subject>Disease Progression</subject><subject>Diuretics - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Evidence-Based Medicine</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Hypertension - physiopathology</subject><subject>Kidney disease</subject><subject>Kidney Diseases - epidemiology</subject><subject>Kidney Diseases - physiopathology</subject><subject>Kidney Diseases - therapy</subject><subject>Renin-Angiotensin System - drug effects</subject><issn>1755-5914</issn><issn>1755-5922</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqNkF1PwjAUhhujEUX_gumlN5v92LrNkBhgAiYEDVG5bLqtC8ON4roF-Pd2Dndtb3rSPu857QMAxMjGZj1sbOy5ruUGhNgEmVOECEP24QxcdRfnXY2dHrjWeoMQQwHDl6BHiNcgwRUYjHKlEvhWSq3rUsJsC5dyK3IYZloKLR_hTO1hpeAwjlWxyzO9htVawqkS-dMNuEhFruXtae-Dj8nz-3hmzV-nL-Ph3IodM9JKGEp8FBOR0MDx_Ij6ggnHiXw_oCzF2InNc9wg9WhEZRpIRvzIZ2lEIpoQylzaB_dt312pvmupK15kOpZ5LrZS1ZpjRKhLGSaeQf0WjUuldSlTviuzQpRHA_HGHd_wRgtv_s8bd_zXHT-Y6N1pSh0VMumCf7IMMGiBfZbL478b83G4NIWJW20805U8dHFRfnHmUc_lq8WUfy5WI28ShjykP-cJiSo</recordid><startdate>201208</startdate><enddate>201208</enddate><creator>Robles, Nicolás R.</creator><creator>Hernandez-Gallego, Roman</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201208</creationdate><title>Blood Pressure in Renal Disease: How to Accomplish the Goal?</title><author>Robles, Nicolás R. ; Hernandez-Gallego, Roman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4060-d60d80c2ad39478b38a6a44b88936f114c27559f73b3ef9e628b86fb2b3d23653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Albuminuria - epidemiology</topic><topic>Albuminuria - therapy</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Blood Pressure - drug effects</topic><topic>Calcium Channel Blockers - therapeutic use</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - physiopathology</topic><topic>Cardiovascular Diseases - prevention & control</topic><topic>Disease Progression</topic><topic>Diuretics - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Evidence-Based Medicine</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Hypertension - physiopathology</topic><topic>Kidney disease</topic><topic>Kidney Diseases - epidemiology</topic><topic>Kidney Diseases - physiopathology</topic><topic>Kidney Diseases - therapy</topic><topic>Renin-Angiotensin System - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robles, Nicolás R.</creatorcontrib><creatorcontrib>Hernandez-Gallego, Roman</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Robles, Nicolás R.</au><au>Hernandez-Gallego, Roman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blood Pressure in Renal Disease: How to Accomplish the Goal?</atitle><jtitle>Cardiovascular therapeutics</jtitle><addtitle>Cardiovasc Ther</addtitle><date>2012-08</date><risdate>2012</risdate><volume>30</volume><issue>4</issue><spage>193</spage><epage>198</epage><pages>193-198</pages><issn>1755-5914</issn><eissn>1755-5922</eissn><abstract>Summary
The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing progression of chronic kidney disease as well as cardiovascular morbidity and mortality in renal patients. The renal results of the ACCOMPLISH trial strongly support the recommendation of using calcium channel blockers as second antihypertensive agent added to renin–angiotensin axis‐blocking drugs. This review discusses the validity of these data and their relationship with the cumulative evidence on the effects of calcium antagonists on renal disease progression.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>22759229</pmid><doi>10.1111/j.1755-5922.2010.00260.x</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 1755-5914 |
| ispartof | Cardiovascular therapeutics, 2012-08, Vol.30 (4), p.193-198 |
| issn | 1755-5914 1755-5922 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1023536127 |
| source | Wiley-Blackwell Open Access Collection |
| subjects | Albuminuria - epidemiology Albuminuria - therapy Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - therapeutic use Blood Pressure - drug effects Calcium Channel Blockers - therapeutic use Cardiovascular Diseases - epidemiology Cardiovascular Diseases - physiopathology Cardiovascular Diseases - prevention & control Disease Progression Diuretics - therapeutic use Drug Therapy, Combination Evidence-Based Medicine Humans Hypertension Hypertension - drug therapy Hypertension - epidemiology Hypertension - physiopathology Kidney disease Kidney Diseases - epidemiology Kidney Diseases - physiopathology Kidney Diseases - therapy Renin-Angiotensin System - drug effects |
| title | Blood Pressure in Renal Disease: How to Accomplish the Goal? |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A50%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blood%20Pressure%20in%20Renal%20Disease:%20How%20to%20Accomplish%20the%20Goal?&rft.jtitle=Cardiovascular%20therapeutics&rft.au=Robles,%20Nicol%C3%A1s%20R.&rft.date=2012-08&rft.volume=30&rft.issue=4&rft.spage=193&rft.epage=198&rft.pages=193-198&rft.issn=1755-5914&rft.eissn=1755-5922&rft_id=info:doi/10.1111/j.1755-5922.2010.00260.x&rft_dat=%3Cproquest_24P%3E1023536127%3C/proquest_24P%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4060-d60d80c2ad39478b38a6a44b88936f114c27559f73b3ef9e628b86fb2b3d23653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1023536127&rft_id=info:pmid/22759229&rfr_iscdi=true |